These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34604097)

  • 41. Tumor-acidity activated surface charge-conversion of polymeric nanocarriers for enhanced cell adhesion and targeted drug release.
    Wu W; Wang J; Lin Z; Li X; Li J
    Macromol Rapid Commun; 2014 Oct; 35(19):1679-84. PubMed ID: 25171076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of drugs and carriers in drug delivery technology and its development.
    Du Y; Chen B
    Drug Des Devel Ther; 2019; 13():1401-1408. PubMed ID: 31118575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of bacterial minicells in cancer therapy].
    Yang Y; Liu Q; Li P; Luo H; Wang H; Kong Q
    Sheng Wu Gong Cheng Xue Bao; 2019 Jun; 35(6):998-1008. PubMed ID: 31231996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel drug delivery system based on hollow mesoporous magnetic nanoparticles for head and neck cancers--targeted therapy
    Zhang Z; Zhuang L; Lin Y; Yan M; Lv J; Li X; Lin H; Zhu P; Lin Q; Xu Y
    Am J Cancer Res; 2020; 10(1):350-364. PubMed ID: 32064172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Nano-in-Nano Polymer-Dendrimer Nanoparticle-Based Nanosystem for Controlled Multidrug Delivery.
    Zhao Z; Lou S; Hu Y; Zhu J; Zhang C
    Mol Pharm; 2017 Aug; 14(8):2697-2710. PubMed ID: 28704056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano-Lipidic Carriers as a Tool for Drug Targeting to the Pilosebaceous Units.
    Ramkar S; Sah AK; Bhuwane N; Choudhary I; Hemnani N; Suresh PK
    Curr Pharm Des; 2020; 26(27):3251-3268. PubMed ID: 32410556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced drug and gene delivery systems based on functional biodegradable polycarbonates and copolymers.
    Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2014 Sep; 190():398-414. PubMed ID: 24858708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy.
    Jia YY; Zhang JJ; Zhang YX; Wang W; Li C; Zhou SY; Zhang BL
    Int J Pharm; 2020 Apr; 580():119190. PubMed ID: 32151664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biocompatible properties of nano-drug carriers using TiO
    Karthika V; Kaleeswarran P; Gopinath K; Arumugam A; Govindarajan M; Alharbi NS; Khaled JM; Al-Anbr MN; Benelli G
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():589-601. PubMed ID: 29853129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.
    Liu B; He D; Wu J; Sun Q; Zhang M; Tan Q; Li Y; Zhang J
    Oncotarget; 2017 May; 8(19):30922-30932. PubMed ID: 28427235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3D nano- and micro-patterning of biomaterials for controlled drug delivery.
    Curry EJ; Henoun AD; Miller AN; Nguyen TD
    Ther Deliv; 2017 Jan; 8(1):15-28. PubMed ID: 27982732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
    Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
    Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs.
    Dai Z; Tu Y; Zhu L
    J Biomed Nanotechnol; 2016 Jun; 12(6):1199-210. PubMed ID: 27319214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.
    Zhang J; Wang L; You X; Xian T; Wu J; Pang J
    Curr Top Med Chem; 2019; 19(1):57-73. PubMed ID: 30686255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.